keyword
https://read.qxmd.com/read/38652340/poorly-differentiated-mucinous-carcinoma-of-the-ascending-colon-complicated-by-bilateral-ovarian-mature-cystic-teratomas-in-a-17-year-old-female-patient-a-case-report
#1
JOURNAL ARTICLE
Takuya Shimogawa, Yukiharu Hiyoshi, Mayuko Ouchi, Keisuke Kosumi, Kojiro Eto, Satoshi Ida, Masaaki Iwatsuki, Yoshifumi Baba, Yuji Miyamoto, Nasa Okazaki, Yuko Miyasato, Hideo Baba
BACKGROUND: Colorectal cancer (CRC) is one of the most common cancers worldwide, and screening colonoscopy has led to a decreasing incidence rate. However, the incidence of CRC is increasing among young people, especially adolescents and young adults (AYAs) who are not routinely screened. Although CRC is the fourth most common cancer among AYAs, it is extremely rare. In younger patients, CRC is often diagnosed later, and the proportion of patients with advanced CRC is higher than that in older patients...
April 23, 2024: Surgical Case Reports
https://read.qxmd.com/read/38652231/diagnostic-and-therapeutic-use-of-oral-micronized-progesterone-in-endocrinology
#2
REVIEW
Eleni Memi, Polina Pavli, Papagianni Maria, Nikolaos Vrachnis, George Mastorakos
Progesterone is a natural steroid hormone, while progestins are synthetic molecules. In the female reproductive system, progesterone contributes to the control of luteinizing hormone and follicle-stimulating hormone secretion and their pulsatility, via its receptors on the kisspeptin, neurokinin B, and dynorphin neurons in the hypothalamus. Progesterone together with estradiol controls the cyclic changes of proliferation and decidualization of the endometrium; exerts anti-mitogenic actions on endometrial epithelial cells; regulates normal menstrual bleeding; contributes to fertilization and pregnancy maintenance; participates in the onset of labor...
April 23, 2024: Reviews in Endocrine & Metabolic Disorders
https://read.qxmd.com/read/38650606/targeting-of-kdm5a-by-mir-421-in-human-ovarian-cancer-suppresses-the-progression-of-ovarian-cancer-cells-retraction
#3
(no author information available yet)
[This retracts the article DOI: 10.2147/OTT.S266211.].
2024: OncoTargets and Therapy
https://read.qxmd.com/read/38650145/chelerythrine-induces-apoptosis-and-ferroptosis-through-nrf2-in-ovarian-cancer-cells
#4
JOURNAL ARTICLE
Jia Zhou, Yuchen Wang, Yangxin Fu, Zhe Lin, He Lin, Guangfu Lv, Ning Kong, Guo Xin, Fang Zhou, Zhidong Qiu, Xiaowei Huang
Ovarian cancer is a prevalent malignancy in the female reproductive system, representing a significantly fatal and incurable tumor. Chelerythrine (CHE), a natural benzopyridine alkaloid, has demonstrated a broad spectrum of anticancer activities. Nevertheless, the ovarian cancer inhibitory impact of CHE remains unclear. In this study, we investigated the cytotoxic mechanism and potential targets of CHE on in vitro cultures of A2780 and SKOV3 cells derived from ovarian cancer. Additionally, in vivo experiments were conducted to confirm the suppressive impact of CHE on tumor growth in nude mice...
March 31, 2024: Cellular and Molecular Biology
https://read.qxmd.com/read/38650029/mesenchymal-stem-cells-promote-ovarian-reconstruction-in-mice
#5
JOURNAL ARTICLE
Jiazhao Li, Haonan Fan, Wei Liu, Jing Zhang, Yue Xiao, Yue Peng, Weijie Yang, Wenwen Liu, Yuanlin He, Lianju Qin, Xiang Ma, Jing Li
BACKGROUND: Studies have shown that chemotherapy and radiotherapy can cause premature ovarian failure and loss of fertility in female cancer patients. Ovarian cortex cryopreservation is a good choice to preserve female fertility before cancer treatment. Following the remission of the disease, the thawed ovarian tissue can be transplanted back and restore fertility of the patient. However, there is a risk to reintroduce cancer cells in the body and leads to the recurrence of cancer. Given the low success rate of current in vitro culture techniques for obtaining mature oocytes from primordial follicles, an artificial ovary with primordial follicles may be a good way to solve this problem...
April 23, 2024: Stem Cell Research & Therapy
https://read.qxmd.com/read/38649975/astaxanthin-suppresses-the-malignant-behaviors-of-nasopharyngeal-carcinoma-cells-by-blocking-pi3k-akt-and-nf-%C3%AE%C2%BAb-pathways-via-mir-29a-3p
#6
JOURNAL ARTICLE
Yajia Xu, Chengyi Jiang
BACKGROUND: As a natural extraction, astaxanthin is gaining increasing attention because of its safety and anti-tumor properties. It has been reported to participate in the progression of various types of cancer such as gastric cancer and ovarian cancer. Nevertheless, the role of astaxanthin in nasopharyngeal carcinoma (NPC) has not been investigated. OBJECT: The study aimed to explore the anticancer mechanism of astaxanthin in regulating NPC cell proliferation, cell cycle progression, apoptosis, migration, and invasion...
April 22, 2024: Genes and Environment: the Official Journal of the Japanese Environmental Mutagen Society
https://read.qxmd.com/read/38647095/extracellular-vesicles-of-bifidobacterium-longum-reverse-the-acquired-carboplatin-resistance-in-ovarian-cancer-cells-via-p53-phosphorylation-on-ser15
#7
JOURNAL ARTICLE
Yun-Long Fan, Jia-Xi Jin, Jun Zhu, Hai-Bo Ruan, Jin-Qun Huang
We previously found that the relative abundance of Bifidobacterium was increased after chemotherapy; however, the role of Bifidobacterium longum in chemotherapeutic drug resistance in ovarian cancer (OVC) remains unclear. This study aimed to understand the potential effects and mechanism of B. longum extracellular vesicles (B. longum-EVs) on carboplatin (CBP) resistance in OVC. Eight normal and 11 ovarian tissues were collected and the expression of B. longum genomic DNA and its association with acquired CBP resistance in OVC patients was determined...
April 22, 2024: Kaohsiung Journal of Medical Sciences
https://read.qxmd.com/read/38646521/immunoglobulins-and-serum-proteins-impair-anti-tumor-nk-cell-effector-functions-in-malignant-ascites
#8
JOURNAL ARTICLE
Antonio Hrvat, Sonja Benders, Rainer Kimmig, Sven Brandau, Nina Mallmann-Gottschalk
INTRODUCTION: Malignant ascites indicates ovarian cancer progression and predicts poor clinical outcome. Various ascites components induce an immunosuppressive crosstalk between tumor and immune cells, which is poorly understood. In our previous study, imbalanced electrolytes, particularly high sodium content in malignant ascites, have been identified as a main immunosuppressive mechanism that impaired NK and T-cell activity. METHODS: In the present study, we explored the role of high concentrations of ascites proteins and immunoglobulins on antitumoral NK effector functions...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38646501/progress-in-cancer-research-on-the-regulator-of-phagocytosis-cd47-which-determines-the-fate-of-tumor-cells-review
#9
REVIEW
Fan Wu, Hongyuan Pang, Fan Li, Mengqing Hua, Chuanwang Song, Jie Tang
Cluster of differentiation 47 (CD47) is a transmembrane protein that is widely and moderately expressed on the surface of various cells and can have an essential role in mediating cell proliferation, migration, phagocytosis, apoptosis, immune homeostasis and other related responses by binding to its ligands, integrins, thrombospondin-1 and signal regulatory protein α. The poor prognosis of cancer patients is closely associated with high expression of CD47 in glioblastoma, ovarian cancer, breast cancer, bladder cancer, colon cancer and hepatocellular carcinoma...
June 2024: Oncology Letters
https://read.qxmd.com/read/38646138/granulosa-cell-tumor-of-the-ovary-a-series-of-6-cases
#10
Rafael Everton Assunção Ribeiro da Costa, Maria Clara Amorim Silva, Erlan Clayton Xavier Cavalcante, Rodrigo de Oliveira Castelo Branco, Cristiane Amaral Dos Reis, Sabas Carlos Vieira
Granulosa cell tumor (GCT) is a rare ovarian malignancy that represents only 2-3% of all cases. There are two subtypes of GCT: juvenile/JGCT (5% of cases) and adult/AGCT (95% of cases). This study aimed to describe a series of 6 GCT cases. The 6 study patients were managed from June 2011 to November 2022 in a private oncology clinic located in Teresina (PI), Brazil. At diagnosis, the mean patient age was 47 years, and symptoms in 5 patients (83%) were pelvic pain and/or increased abdominal volume. The majority of the patients (N=4/67%) had no comorbidities or findings related to GCT on physical examination...
2024: Pan African Medical Journal
https://read.qxmd.com/read/38645412/link-a-unveiling-its-functional-role-and-clinical-significance-in-human-tumors
#11
REVIEW
Bing Liao, Jialing Wang, Yilin Xie, Hongliang Luo, Jun Min
LINK-A, also recognized as LINC01139, has emerged as a key oncological lncRNA in cancer. LINK-A is upregulated in solid and liquid tumor samples, including breast cancer, ovarian cancer, glioma, non-small-cell lung cancer, and mantle cell lymphoma. Notably, LINK-A is involved in regulating critical cancer-related pathways, such as AKT and HIF1α signaling, and is implicated in a range of oncogenic activities, including cell proliferation, apoptosis, epithelial-mesenchymal transition (EMT), cell invasion and migration, and glycolysis reprogramming...
2024: Frontiers in Cell and Developmental Biology
https://read.qxmd.com/read/38645227/muscle-weakness-and-mitochondrial-stress-occur-before-metastasis-in-a-novel-mouse-model-of-ovarian-cancer-cachexia
#12
Luca J Delfinis, Leslie M Ogilvie, Shahrzad Khajehzadehshoushtar, Shivam Gandhi, Madison C Garibotti, Arshdeep K Thuhan, Kathy Matuszewska, Madison Pereira, Ronald G Jones, Arthur J Cheng, Thomas J Hawke, Nicholas P Greene, Kevin A Murach, Jeremy A Simpson, Jim Petrik, Christopher G R Perry
OBJECTIVES: A high proportion of women with advanced epithelial ovarian cancer (EOC) experience weakness and cachexia. This relationship is associated with increased morbidity and mortality. EOC is the most lethal gynecological cancer, yet no preclinical cachexia model has demonstrated the combined hallmark features of metastasis, ascites development, muscle loss and weakness in adult immunocompetent mice. METHODS: Here, we evaluated a new model of ovarian cancer-induced cachexia with the advantages of inducing cancer in adult immunocompetent C57BL/6J mice through orthotopic injections of EOC cells in the ovarian bursa...
April 8, 2024: bioRxiv
https://read.qxmd.com/read/38645136/collateral-damage-of-nudt15-deficiency-in-cancer-provides-a-cancer-pharmacogenetic-therapeutic-window-with-thiopurines
#13
Jacob C Massey, Joseph Magagnoli, S Scott Sutton, Phillip J Buckhaults, Michael D Wyatt
Genome instability is a hallmark of cancer and are driven by mutations in oncogenes and tumor suppressor genes. Despite successes seen with select targeted therapeutics, this type of personalized medicine is only beneficial for a small subpopulation of cancer patients who have one of a few actionable genetic changes. Most tumors also contain hundreds of passenger mutations that offered no fitness advantage or disadvantage during tumor evolution. Mutations in known pharmacogenetic (PGx) loci for which germline variants encode variability in drug response can cause somatically acquired drug sensitivity...
April 11, 2024: bioRxiv
https://read.qxmd.com/read/38643508/acid-sensitive-outwardly-rectifying-cl-current-in-ov2944-mouse-ovarian-cancer-cells
#14
JOURNAL ARTICLE
Hajime Hirasawa, Kayo Aoba, Naofumi Miwa
BACKGROUND/AIMS: Extracellular acidic conditions impair cellular activities; however, some cancer cells drive cellular signaling to adapt to the acidic environment. It remains unclear how ovarian cancer cells sense changes in extracellular pH. This study was aimed at characterizing acid-inducible currents in an ovarian cancer cell line and evaluating the involvement of these currents in cell viability. METHODS: The biophysical and pharmacological properties of membrane currents in OV2944, a mouse ovarian cancer cell line, were studied using the whole-cell configuration of the patch-clamp technique...
April 20, 2024: Cellular Physiology and Biochemistry
https://read.qxmd.com/read/38642937/phase-1a-dose-escalation-study-of-ivonescimab-ak112-smt112-an-anti-pd-1-vegf-a-bispecific-antibody-in-patients-with-advanced-solid-tumors
#15
JOURNAL ARTICLE
Sophia Frentzas, Anna Rachelle Austria Mislang, Charlotte Lemech, Adnan Nagrial, Craig Underhill, Wenjing Wang, Zhongmin Maxwell Wang, Baiyong Li, Yu Xia, Jermaine I G Coward
BACKGROUND: Studies showed that vascular endothelial growth factor (VEGF) inhibitors could improve therapeutic efficacy of PD-1/PD-L1 antibodies by transforming the immunosuppressive tumor microenvironment (TME) into an immunoresponsive TME. Ivonescimab is a first-in-class, humanized tetravalent bispecific antibody targeting PD-1 and VEGF-A simultaneously. Here, we report the first-in-human, phase 1a study of ivonescimab in patients with advanced solid tumors. METHODS: Patients with advanced solid tumors were treated with ivonescimab 0...
April 19, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38642782/cxxc5-drove-inflammation-and-ovarian-cancer-proliferation-via-transcriptional-activation-of-znf143-and-egr1
#16
JOURNAL ARTICLE
Ting Geng, Qigang Sun, Jingliang He, Yulu Chen, Wenhao Cheng, Jing Shen, Bin Liu, Meiqi Zhang, Sen Wang, Kadirya Asan, Mengwei Song, Qi Gao, Yizhuo Song, Ruotong Liu, Xing Liu, Yuanyuan Ding, Aixin Jing, Xiaoqing Ye, Hongyu Ren, Kaile Zeng, Ying Zhou, Boyu Zhang, Shaojie Ma, Wei Liu, Shunfang Liu, Jing Ji
CXXC5, a zinc-finger protein, is known for its role in epigenetic regulation via binding to unmethylated CpG islands in gene promoters. As a transcription factor and epigenetic regulator, CXXC5 modulates various signaling processes and acts as a key coordinator. Altered expression or activity of CXXC5 has been linked to various pathological conditions, including tumorigenesis. Despite its known role in cancer, CXXC5's function and mechanism in ovarian cancer are unclear. We analyzed multiple public databases and found that CXXC5 is highly expressed in ovarian cancer, with high expression correlating with poor patient prognosis...
April 18, 2024: Cellular Signalling
https://read.qxmd.com/read/38642607/deciphering-a-gpcr-lncrna-mirna-nexus-identification-of-an-aberrant-therapeutic-target-in-ovarian-cancer
#17
JOURNAL ARTICLE
Ji Hee Ha, Rangasudhagar Radhakrishnan, Revathy Nadhan, Rohini Gomathinayagam, Muralidharan Jayaraman, Mingda Yan, Srishti Kashyap, Kar-Ming Fung, Chao Xu, Resham Bhattacharya, Priyabrata Mukherjee, Ciro Isidoro, Yong Sang Song, Danny N Dhanasekaran
Ovarian cancer ranks as a leading cause of mortality among gynecological malignancies, primarily due to the lack of early diagnostic tools, effective targeted therapy, and clear understanding of disease etiology. Previous studies have identified the pivotal role of Lysophosphatidic acid (LPA)-signaling in ovarian cancer pathobiology. Our earlier transcriptomic analysis identified Urothelial Carcinoma Associated-1 (UCA1) as an LPA-stimulated long non-coding RNA (lncRNA). In this study, we elucidate the tripartite interaction between LPA-signaling, UCA1, and let-7 miRNAs in ovarian cancer progression...
April 18, 2024: Cancer Letters
https://read.qxmd.com/read/38640869/identification-of-a-new-bisindolinone-arresting-igrov1-cells-proliferation
#18
JOURNAL ARTICLE
Rita Morigi, Chiara Zalambani, Giovanna Farruggia, Laura Verardi, Daniele Esposito, Alberto Leoni, Francesca Borsetti, Manuela Voltattorni, Laura Zambonin, Luca Pincigher, Natalia Calonghi, Alessandra Locatelli
In an initial screening, a series of novel Knoevenagel adducts were submitted to the National Cancer Institute for evaluation of antitumor activity in human cell lines. In particular, compound 5f showed remarkable selectivity against IGROV1, an ovarian cancer cell line, without affecting healthy human fibroblast cells. Analyses of cytotoxicity, cell proliferation, cell migration, epigenetic changes, gene expression, and DNA damage were performed to obtain detailed information about its antitumor properties...
April 2, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38640784/implantable-car-t-cell-factories-enhance-solid-tumor-treatment
#19
JOURNAL ARTICLE
Sharda Pandit, Pritha Agarwalla, Feifei Song, Anton Jansson, Gianpietro Dotti, Yevgeny Brudno
Chimeric Antigen Receptor (CAR) T cell therapy has produced revolutionary success in hematological cancers such as leukemia and lymphoma. Nonetheless, its translation to solid tumors faces challenges due to manufacturing complexities, short-lived in vivo persistence, and transient therapeutic impact. We introduce 'Drydux' - an innovative macroporous biomaterial scaffold designed for rapid, efficient in-situ generation of tumor-specific CAR T cells. Drydux expedites CAR T cell preparation with a mere three-day turnaround from patient blood collection, presenting a cost-effective, streamlined alternative to conventional methodologies...
April 15, 2024: Biomaterials
https://read.qxmd.com/read/38640774/the-karyometric-signature-is-altered-in-fallopian-tubes-with-serous-tubal-intraepithelial-carcinoma
#20
JOURNAL ARTICLE
Gustavo C Rodriguez, Michael Yozwiak, Omar L Nelson, Hao Helen Zhang, Ahyoung Amy Kim, William Watkin, Jennifer K Barton, David S Alberts
OBJECTIVE: Recent evidence suggests that the fimbriated end of the fallopian tube harbors the precursor cells for many high-grade ovarian cancers, opening the door for development of better screening methods that directly assess the fallopian tube in women at risk for malignancy. Previously we have shown that the karyometric signature is abnormal in the fallopian tube epithelium in women at hereditary risk of ovarian cancer. In this study, we sought to determine whether the karyometric signature in serous tubal intraepithelial carcinoma (STIC) is significantly different from normal, and whether an abnormal karyometric signature can be detected in histologically normal tubal epithelial cells adjacent to STIC lesions...
April 18, 2024: Gynecologic Oncology
keyword
keyword
50237
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.